局所ドラッグデリバリー市場- 世界の産業規模、シェア、動向、機会、予測、製品別、投与経路別、エンドユーザー別、地域別、競合別、2020～2030年

局所ドラッグデリバリーの世界市場規模は2024年に2,443億5,000万米ドルで、2030年には4,051億米ドルに達し、CAGR 8.75％で成長すると予測されています。

この成長の原動力は、特に高齢者、小児、慢性疾患患者などの社会的弱者における、非侵襲的な標的治療に対する需要の増加です。皮膚や粘膜組織に直接塗布する局所ドラッグデリバリーは、局所的な治療効果と最小限の全身曝露で支持されています。市場の拡大は、脂質ベースシステムやマイクロニードルパッチのような製剤技術の革新と、合理化された規制経路によってさらに支えられています。さらに、健康意識の高まりが皮膚科、創傷治療、疼痛管理における局所・経皮製品の採用を後押ししています。製薬企業がより患者中心で外来患者に優しいソリューションに軸足を移す中、局所ドラッグデリバリーは現代のヘルスケア戦略に不可欠な存在になりつつあります。

市場促進要因

皮膚疾患および慢性疾患の有病率の上昇

主な市場課題

皮膚透過性の制限と製剤の複雑さ

主要市場動向

先進ドラッグデリバリー技術の採用拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 局所ドラッグデリバリー市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（半固形製剤、液状製剤、固形製剤、経皮吸収型製剤）
  • 投与経路別（経皮ドラッグデリバリー、眼科ドラッグデリバリー、直腸ドラッグデリバリー、経鼻薬ドラッグデリバリー）
  • エンドユーザー別（病院、診療所、在宅ヘルスケア、診断センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の局所ドラッグデリバリー市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の局所ドラッグデリバリー市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の局所ドラッグデリバリー市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の局所ドラッグデリバリー市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの局所ドラッグデリバリー市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の局所ドラッグデリバリー市場：SWOT分析

第14章 競合情勢

• Johnson & Johnson Services, Inc.
• Nestle SA
• GlaxoSmithKline Plc
• Novartis AG
• Merck & Co. Inc.
• Crescita Therapeutics Inc.
• Cipla Ltd.
• Taro Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International Inc.
• Glenmark Pharmaceuticals Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Topical Drug Delivery Market was valued at USD 244.35 Billion in 2024 and is projected to reach USD 405.10 Billion by 2030, growing at a CAGR of 8.75%. This growth is driven by the increasing demand for non-invasive, targeted therapies, especially among vulnerable populations such as the elderly, children, and those with chronic conditions. Topical drug delivery, which involves direct application to the skin or mucosal tissues, is favored for its localized therapeutic effects and minimal systemic exposure. Market expansion is further supported by innovations in formulation technologies like lipid-based systems and microneedle patches, coupled with streamlined regulatory pathways. Additionally, growing health awareness is boosting the adoption of topical and transdermal products in dermatology, wound care, and pain management. As pharmaceutical firms pivot toward more patient-centric and outpatient-friendly solutions, topical drug delivery is becoming an integral part of modern healthcare strategies.

Key Market Drivers

Rising Prevalence of Skin Disorders and Chronic Diseases

Skin disorders are among the most widespread medical conditions globally, impacting individuals of all ages. The growing incidence of issues such as acne, eczema, psoriasis, dermatitis, fungal infections, and rosacea is linked to changing environmental factors, lifestyle habits, genetic predispositions, and heightened diagnosis rates. According to the Global Burden of Disease Study, over 1.9 billion people are affected by skin conditions worldwide, making it a critical public health concern. Chronic skin ailments often require continuous or recurring treatment, with topical formulations offering targeted application and fewer systemic side effects. Acne alone affects approximately 9.4% of the global population and ranks as the eighth most prevalent skin disease. Its high incidence, particularly among adolescents and young adults-where rates can reach 28.3%-creates a robust market opportunity for both over-the-counter and prescription topical treatments. This sustained and growing prevalence ensures consistent demand for topical dermatological products.

Key Market Challenges

Limited Skin Permeability and Formulation Complexity

A key obstacle to market advancement is the restricted permeability of human skin, especially when attempting to deliver drugs with large molecular sizes, hydrophilic properties, or instability. The outermost skin layer, the stratum corneum, serves as a significant barrier to most active pharmaceutical ingredients, particularly biologics, proteins, and peptides. Successfully formulating compounds that can penetrate this layer without compromising safety and efficacy remains a technical challenge. Furthermore, the development of innovative topical delivery systems-such as microneedles, nano-based carriers, or vesicular formulations-demands substantial R&D investment, specialized knowledge, and intricate manufacturing processes. These challenges constrain the variety of drugs suitable for topical delivery and lead to extended product development timelines and increased costs.

Key Market Trends

Growing Adoption of Advanced Drug Delivery Technologies

A prominent trend in the topical drug delivery market is the increased adoption of advanced technologies aimed at enhancing drug stability, skin penetration, and bioavailability. Nanotechnology-enabled systems, including liposomes, niosomes, and solid lipid nanoparticles, are facilitating deeper and more targeted delivery of active ingredients. Additionally, devices like microneedle patches and transdermal systems are opening up new possibilities for administering complex molecules such as peptides and vaccines through the skin. These innovations not only improve treatment outcomes but also extend product lifecycles and enable differentiation in competitive markets. The ability to provide controlled, localized, and sustained drug release is drawing investment and driving robust R&D across the pharmaceutical landscape.

Key Market Players

• Johnson & Johnson Services, Inc.
• Nestle SA
• GlaxoSmithKline Plc
• Novartis AG
• Merck & Co. Inc.
• Crescita Therapeutics Inc.
• Cipla Ltd.
• Taro Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International Inc.
• Glenmark Pharmaceuticals Ltd

Report Scope:

In this report, the Global Topical Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Topical Drug Delivery Market, By Product:

• Semi-Solid Formulations
• Liquid Formulations
• Solid Formulations
• Transdermal Products

Topical Drug Delivery Market, By Route of Administration:

• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Nasal Drug Delivery

Topical Drug Delivery Market, By End User:

• Hospitals
• Clinics
• Home Healthcare
• Diagnostic Centers
• Others

Topical Drug Delivery Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Topical Drug Delivery Market.

Available Customizations:

Global Topical Drug Delivery market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Topical Drug Delivery Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
  • 5.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Nasal Drug Delivery)
  • 5.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Topical Drug Delivery Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Route of Administration
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Topical Drug Delivery Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Topical Drug Delivery Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Topical Drug Delivery Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By End-User

7. Europe Topical Drug Delivery Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Route of Administration
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Topical Drug Delivery Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Topical Drug Delivery Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By End-User
  • 7.3.3. Italy Topical Drug Delivery Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By End-User
  • 7.3.4. France Topical Drug Delivery Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Topical Drug Delivery Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Topical Drug Delivery Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Route of Administration
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Topical Drug Delivery Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Topical Drug Delivery Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Topical Drug Delivery Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Topical Drug Delivery Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Topical Drug Delivery Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By End-User

9. South America Topical Drug Delivery Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Route of Administration
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Topical Drug Delivery Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Topical Drug Delivery Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Topical Drug Delivery Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Topical Drug Delivery Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Route of Administration
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Topical Drug Delivery Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Topical Drug Delivery Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Topical Drug Delivery Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Johnson & Johnson Services, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Nestle SA
• 14.3. GlaxoSmithKline Plc
• 14.4. Novartis AG
• 14.5. Merck & Co. Inc.
• 14.6. Crescita Therapeutics Inc.
• 14.7. Cipla Ltd.
• 14.8. Taro Pharmaceutical Industries Ltd.
• 14.9. Valeant Pharmaceuticals International Inc.
• 14.10.Glenmark Pharmaceuticals Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer